Contrast and virtual colonoscopy accessory developer E-Z-EM reported a slight uptick in net sales and profit for its fiscal 2007 second quarter.
For the period (end-December 2), the Lake Success, NY-based firm posted net sales from continuing operations of $34.2 million for the quarter, up 1% compared with net sales of $33.8 million for the same quarter of fiscal 2006.
Net earnings from continuing operations for the period also showed growth, with the firm recording a profit of $1.8 million, compared with net earnings from continuing operations for the same period last year of $1.6 million.
The company said that sales in the quarter were driven by CT imaging products, which collectively grew 19% over the prior-year period, and its virtual colonoscopy products, which increased approximately 30% over the prior-year period.
E-Z-EM also reaffirmed its financial guidance for fiscal-year 2007 with net sales estimated to be at least $147 million and net earnings of at least $7.4 million.
By AuntMinnie.com staff writers
January 10, 2007
Related Reading
E-Z-EM debuts EmpowerMR at RSNA, November 29, 2006
E-Z-EM receives FDA OK for EmpowerSync, November 29, 2006
Road to RSNA, E-Z-EM, October 26, 2006
E-Z-EM posts Q1 downturn, October 11, 2006
E-Z-EM signs Amerinet, September 11, 2006
Copyright © 2007 AuntMinnie.com




















![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&fit=crop&h=112&q=70&w=112)